Request Demo
Last update 20 Mar 2025
Ginkgo Leaves Capsule
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Herbal medicine |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (26 May 2020), |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Ginkgo Leaves CapsuleCTR20160043
银杏叶胶囊对原发性开角型青光眼-瘀血阻络证视功能影响作用的随机、双盲、安慰剂平行对照、多中心临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical trial on the effects of Ginkgo biloba capsule on visual function in primary open-angle glaucoma with blood stasis and obstruction of collaterals
NCT00029692
Effects of Ginseng and Ginkgo on Drug Disposition in Man
100 Clinical Results associated with Ginkgo Leaves Capsule
Login to view more data
100 Translational Medicine associated with Ginkgo Leaves Capsule
Login to view more data
100 Patents (Medical) associated with Ginkgo Leaves Capsule
Login to view more data
4
Literatures (Medical) associated with Ginkgo Leaves Capsule01 Jan 2011Therapeutische Umschau
Phytopharmaka als Ursache von unerwünschten Arzneimittelwirkungen
Article
Author: Hafner-Blumenstiel, Verena
01 Sep 2009Pharmazie in unserer Zeit
Von Ginkgo über GbL zu EGb – ein langer Weg zum rationalen Phytopharmakon. Die Arzneipflanze mit dem seltsamsten Namen
Article
Author: Caesar, Wolfgang
01 Aug 2007Zeitschrift für Gerontologie und GeriatrieQ4 · MEDICINE
Stellungnahme zum IQWiG-Vorbericht A05-19B „Ginkgohaltige Präparate bei Alzheimer Demenz“
Q4 · MEDICINE
Article
Author: Hansjörg Werner ; Manfred Gogol ; Cornel Sieber ; Dieter Lüttje
100 Deals associated with Ginkgo Leaves Capsule
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Angina Pectoris | China | 26 May 2020 | |
| Brain Infarction | China | 26 May 2020 | |
| Coronary Artery Disease | China | 26 May 2020 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glaucoma, Open-Angle | Phase 3 | China | 22 Jul 2015 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free